Xiangya Second Hospital of Central South University
Xiangya Second Hospital of Central South University
Changsha, Hunan, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer. | Ovarian Cancer Recurrent | Recruiting | Early phase 1 | 2024-10-28 | NCT06660511 |